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Abstract. Our contribution to the expanding literature on the globalization of research and 
innovation is to investigate the extent to which sector-specific developments in an 
emerging technology (such as increasing interdisciplinarity and complexity) affect 
inventive activities developed abroad. We look at how technological diversity and 
scientific excellence of host countries in the field of nanotechnology affect the 
development of inventive activities by US multinational companies (MNCs). We identify 
the most active US-based MNCs in nanotechnology-related patenting and examine 
location decisions of these companies and their international subsidiaries. Econometric 
results confirm our hypothesis that the technological breadth of host countries positively 
influences the expected number of inventions developed abroad by US MNCs. Science 
capabilities of countries also have a positive impact on the decision to invent abroad, 
while the influence of market specific factors is less clear. We interpret these results as 
suggesting that host country science capabilities are important to attract innovative 
activities by MNCs, but as the interdisciplinary and convergent nature of nanotechnology 
evolves, access to a broadly diversified knowledge base becomes important in increasing 
the relative attractiveness of host locations. 
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1. Introduction 
In recent years there has been growing theoretical and empirical debate about the types of 
research and innovation activities that multinational corporations (MNCs) can and do 
perform abroad. According to new decentralized competence models (Cantwell 1995; 
Blanc and Sierra 1999; Dunning and Narula 1995; Florida 1997; Kuemmerle 1999; 
Zanfei 2000; Kumar 2001; and Frost 2001), decisions about what research and innovation 
activities to undertake abroad now occur in an era characterized by increased 
globalization of competencies in science and technology. With greater choice about 
where to locate high-potential research and innovation, the location selection process 
becomes more complex and increasingly sensitive to the characteristics of host country 
innovation systems. 
Empirical papers that have examined how local research environments affect the 
internationalization process of research and innovation generally find that countries with 
stronger scientific and technological capabilities (Guellec and van Pottelsberghe 2001; Le 
Bas and Sierra 2002; Feinberg and Gupta 2004; Belderbos 2006; Thursby and Thursby 
2006; Ito and Wakasugi, 2007) and countries which provide certain guarantees regarding 
intellectual property protection methods attract more inventive activities by foreign 
MNCs (Branstetter et al. 2005; Hagedoorn et al. 2005; Wakasugi and Ito 2007). 
While this research has improved understanding about how the nature of local 
innovation systems affects the internationalization of R&D, several questions remain 
unanswered. For example, we do not know much about how systems respond to the 
changing stages of emergence of a given technology. Nor do we know enough about how 
the increasing sophistication of a technology affects location decision processes and the 
attractiveness of host innovation systems. In this paper, we try to answer these questions 
for the emerging field of nanotechnology.  
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As a current emergent domain of new technology, we expect nanotechnology to 
be subject to the latest strategies of R&D management and location adopted by MNCs. 
But there might be some phasing, as nanotechnology develops from initial research to 
simple applications to more sophisticated and complex products and devices. We 
postulate that as the nanotechnology field evolves, corporations will likely adopt the 
latest development techniques at the frontier of new MNC research and innovation 
strategies, seeking the attractiveness of locations with a strong research base in 
nanotechnology. Yet, the increasing interdisciplinary and convergent character of 
nanotechnology may come into play as the technology becomes more sophisticated. 
Local innovation systems with a deep array of diverse disciplinary strengths and highly-
qualified capabilities might then be attractive locations to conduct complex research.  
To test our ideas, we construct a balanced panel of US-owned corporations with 
nanotechnology activities during 1997-2006 and estimate a series of count-based models 
on the number of patents invented in host countries by these companies. The data come 
from several sources, including a rich database of nanotechnology patents built using 
MicroPatent and INPADOC data, publication records from the Science Citation Index 
(SCI) database in the Web of Science, USPTO patents assigned to corporate companies 
in all technological fields, and macroeconomic data from the World Bank. Due to the 
longitudinal nature of our data, we are able to estimate dynamic relationships between the 
dependent variable and explanatory variables.  
Our results contribute to a series of interesting empirical findings. We find that 
technological diversity in nanotechnology, measured by the lagged value of the reciprocal 
of the Gini coefficient, increases the expected number of patents invented by a US MNC 
in a foreign country. Scientific strength, measured by the average number of science and 
technical publications originating in a host country, is also significant and positively 
associated with the quantity of inventions a US MNC develops abroad. The level of 
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scientific excellence in nanotechnology, measured as the weighed number of publication 
citations in the five years prior to the inventive process, also increases the expected 
number of patents invented abroad, but to a lesser extent. By contrast, the influence of 
traditional market driven factors, such as market size, is less clear.  
The paper is organized as follows. Section 2 explains our hypothesis, research 
questions and empirical model. Section 3 reviews data sources and data characteristics. 
Section 4 describes estimation methods and econometric results. Section 5 closes the 
paper with some concluding comments and policy implications.  
 
2. Analytical framework 
Modern theories about the reasons behind the globalization of research and innovation 
point to the changing role of MNC location strategies.1 Florida (1997), for example, 
argues that global R&D not only serves the purpose of creating “listening posts” to 
monitor the scientific and technological capabilities of domestic firms and universities, 
but also for creating knowledge “generating stations” which generate new scientific and 
technological capabilities. Kuemmerle (1999) adds that global R&D may be viewed as a 
way to adapt technology generated at home to local production (which he coins as 
“home-based exploiting” R&D), or as a way to increase the productivity of domestic 
R&D (denoted as “home-based-augmenting” R&D).  
Dunning and Narula (1995) associate this process of increasing home-based 
capabilities with the search for strategic assets that are specific to other firms and 
locations. The intrinsic tacitness of these activities and the firm’s desire to absorb as 
much local knowledge as possible implies that affiliates engage into more sophisticated 
R&D activities in locations which exhibit a comparative technological advantage relative 
to the home location of the MNCs. Cantwell (1995) suggests that MNCs locate 
                                                 
1 See Narula and Zanfei (2004) for a recent survey.   
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innovation activities abroad to take advantage of agglomeration economies and benefits 
from locational divisions of labor. More recently, Narula and Zanfei (2005) and 
Criscuolo et al. (2005) suggest that both the evolving nature of host and home innovation 
systems may affect the types of innovation firms develop abroad. 
In this paper, we seek to contribute to this literature by suggesting that under 
conditions of increasing global competitiveness across locations, some new explanatory 
factors should be explored in order to better understand firms’ location decisions. We 
first propose that the internationalization of inventive activities may vary according to the 
stage of technological trajectory. It is plausible that the benefits of polycentric R&D are 
related to the development stage of a technology. Hagedoorn and Narula (1996) state that 
in industries characterized by rapid technological developments and high uncertainties, 
organizational flexibility and speed of information are vital. Archibugi and Michie (1995) 
observe that this is particularly true in industries in their infant states, where there is 
greater need for new knowledge and for sharing it. Thus, as a technology evolves, the 
need for foreign knowledge may change, based on what companies have learned in their 
early forays, their research and investment strategies, the regional availability of 
advanced technological capabilities, and the balance between knowledge-seeking and 
knowledge-protection.  
Traditional location factors such as market size (Vernon 1966) may attract 
inventive activities that are more applied in nature. Such factors may be important where 
innovations are incremental and close to market but less important where more 
exploratory research is being undertaken. Having strong scientific capabilities may attract 
inventive activities with an explorative component in the development stages of a 
technology. However, in more mature stages, more sophisticated factors such as scientific 
excellence and a diverse knowledge base may attract inventive activities which are more 
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complex and multidisciplinary. As a result we propose that inter-industry spillovers and 
diversity externalities should be taken into account in this new context. 
We also propose to consider the level and quality of the science base in attracting 
early-stage research and innovation in emerging technologies. Scientific activity is 
increasing in several rapidly developing economies, particularly in China and India. In 
China, for example, R&D intensity (R&D expenditures as a percentage of the gross 
domestic product) increased from 0.69 in 1998 to 1.34 in 2005, rising from about 32 
percent to almost 60% of the average for developed (OCED) countries over this period 
(National Science Board 2002 & 2008). A significant share of these additional R&D 
resources has been channeled into new fields such as nanotechnology, where China is 
now the second largest national producer of scientific publications after the United States 
(Kostoff et al. 2007). Although still below the level of the US, the aggregated quality of 
China’s nanotechnology research, as measured by citations to it, is increasing (Zucker 
and Darby, 2005; Youtie et al. 2008). Perhaps more important than aggregates, several 
top Chinese universities and units of the Chinese Academy of Sciences have emerged as 
leading centers of nanotechnology research (Tang and Shapira 2008). 
The emerging field of nanotechnology is the focus of our exploratory analysis. 
Nanotechnology involves manipulating molecular-sized materials to create new products 
and process with novel features due to their nanoscale properties and is widely 
anticipated as one of the next drivers of technology-based business and economic growth 
around the world (Lux Research, 2004).2 We believe that this field is an appropriate one 
                                                 
2 A distinction should be made between the terms nanoscience and nanotechnology. Nanoscience 
refers to the search for fundamental new knowledge to understand structures, materials, and 
components at the scale of roughly 1-100 nanometers (nm). Nanotechnology is a broader concept 
that refers to the application of that knowledge to design and use. More formally, we can say that 
nanotechnology consists of the creation of systems, devices, structures and materials at the 1 – 100 
nanometer scale with novel properties and functions because of their small size (PCAST, 2005). 
Whereas the growth of codified knowledge in nanoscience can be captured by examination of 
scientific publication, for nanotechnology the intrinsic characteristics of patents (novelty, non-
obviousness, and usefulness) make them appropriate for analyzing the development and 
application potential of this emerging technology.  
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to test our hypotheses. Although there is debate as to the direction and relationships of 
development in nanotechnology (see, for example, Bonaccorsi and Thoma 2007), several 
studies have argued that nanotechnology is a convergent scientific domain that uses 
diverse knowledge bases and enables technological changes in other fields.  
Reports by Rocco and Bainbridge (2003) and Nordmann (2004), find that 
nanotechnology covers multiple disciplines, including engineering, biology, chemistry, 
materials science and computing. Avenel et al. (2007) also demonstrate, with the use of 
Herdfindahl indexes, how the breadth of corporate publications and patents in 
nanotechnology over the period 1993-2003 spread over a large number of fields, 
regardless of firm size. It is possible that the multidisciplinary nature of nanotechnology 
will result in locational patterns that differ from those found for prior technologies which 
are more specialized. We suggest that the emerging complexity and convergence of 
nanotechnology may induce corporate research and innovation in this field to cluster in 
certain locations which possess a breadth of research capabilities as corporations 
recognize the importance over time of this domain.   
 
2.1 Empirical model 
Building on our review of prior theoretical and empirical findings, we suggest that the 
nature and development of MNC inventive activities is influenced by three set of factors: 
characteristics of home-country and host-country innovation systems, MNCs strategic 
decisions on where, how and what to locate abroad, and the role of subsidiaries’ 
development. To understand how these factors affect MNCs location decisions, we 
propose to make a distinction between country of origin of MNCs, while considering a 
set of innovation characteristics of host-countries, MNCs and subsidiaries.3 In addition, 
                                                 
3 Instead of limiting the analysis to a particular country of origin of MNCs, another 
methodological solution could be to use dummy variables for each country of origin of MNCs. 
However, country comparability is problematic because there are country biases in the use of 
different patent offices (Schmoch, 2007). As a result, our empirical model focuses on MNCs from 
a specific country. 
 8
our contribution emphasizes the need to consider specific evolving elements of the 
technology developed abroad and the role of scientific and technological spillovers 
within disciplines. In particular we postulate that in nanotechnology the multidisciplinary 
nature of the field and the quality of related scientific codified knowledge may affect 
MNCs decisions as well. We therefore set up to estimate the following empirical model 
for a group of US-based MNCs.,  
 
Pijt =b1x1jt-1+ b2x2jt-1+Σkbk xkjt-1 + Σ nbn xnit-1 + eijt    [1] 
 
where Pijt is the number of patents invented in a host country j by a given firm i during t,4 
x1jt-1 stands for technological diversity of host county j during time t-1 and x2jt-1 is 
scientific excellence of host county j during time t-1. xkjt-1 is a vector of host country 
characteristics that we control for, including market size and overall scientific strength, 
xnit-1, is a vector of MNCs and subsidiaries’ characteristics, including past inventive 
experience in host countries, firm’s capacity for patenting R&D and pre-sample patents 
in nanotechnology. e ijt  stands for random error terms.5 
 
Explanatory variables of interest 
Technological diversity in nanotechnology of host countries 
Technological diversity captures whether the breadth of nanotechnology patents invented 
in host countries is spread over a large number of technology domains or whether it 
                                                 
4 In total our sample size consists of 625 observations. These observations correspond to the total 
number of US assignees multiplied the total number of host countries with one patent invented 
totally or partially abroad and assigned to those corporations. We find that the US companies in 
our sample invent in a total of 25 host countries. Each observation is therefore unique for each 
company and each location. 
5 The use of patents as indicator of inventive activity has long been emphasized in the literature 
(see Griliches, 1990, for a review). Despite the technical difficulties associated with patents and 
the fact that not all inventions are patentable, patent documents are rich information sources that 
can be used to study, among other topics, the geographic distribution of particular inventions. By 
limiting the analysis to a specific domain, we reduce potential differences that could emerge 
between fields and industries with different propensities to patent (Arundel and. Kabla, 1998). 
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remains concentrated in few fields. To compute this measure we propose to use the 























where n is the total number of technology domains in which a country is patenting, j is 
the technological domain defined by patent class, CPij is the cumulative sum of patents by 
county i in technology field j, ranged in increasing order, and Pij is the number of patents 
in each technological class.6 This index varies between 0 and 1, with larger values 
indicating greater diversity. It is appropriate in our case because, as posed by van 
Zeebroeck et al.  (2006), the Gini index is the most sensitive indicator to the presence of a 
large number of small patent classes.  
In the industrial organization literature, the scope of a patent has been related 
with the economic value of a patent (Lerner 1994). The more general the research content 
of a patent, the greater the ability of the assignee to secure markets in different fields and 
the higher the probability to be cited by patents in different technology classes. In the 
economic geography literature, it has been suggested that the patent scope is also a good 
proxy to measure the presence of inter-industry spillovers and diversity externalities 
(Cantwell and Piscitello 2005). We interpret a significant and positive coefficient of our 
measure of technological diversity as a signal of the presence of these positive 
externalities. 
 
                                                 
6 Patent scopes indexes are generally computed using the International Patent Classification (IPC) 
class in which a patent office assigns a patent (see, for example, Cassiman et al. 2006). As 
explained below, we use this classification at the three-digit level. 
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Scientific excellence in nanotechnology of host countries 
To measure to what extent host countries’ nanotechnology scientific excellence affects 
the conduct of invention activities of foreign firms, we propose to look at the 
nanotechnology publications of host countries and the number of times those host country 
publications have been cited. Accordingly, a citation index is defined. Cj=(∑ xkj* ck /Xj), 
where ck is the number of times a publication is cited, xkj is the number of publications 
cited ck times in each host country j, and X is the total number of publications originating 
in the country.  
 
Country-level control variables 
Market size of host countries 
The impact of host country market size on the conduct of R&D has long been discussed 
in the literature (see, for example, Vernon 1966, 1979; Mansfield et al. 1979). However, 
empirical evidence on this issue remains ambiguous. Belderbos (2006), for example, 
finds that the market size of a host country increases the expected number of patents of an 
affiliate by about 25%, but when controlling for an affiliate’s location in Asian regions, 
market size variables become negative. Ambiguous results are also found in Almeida and 
Phene’s (2004) analysis of foreign subsidiaries of US semiconductor firms.  
By contrast, Kumar (2001) in a cross-country comparison of Japanese and US 
R&D finds a positive impact of market size on the level of R&D expenditures of 
affiliates. Similarly, Odagiri and Yasuda (1996), in their examination of R&D activities 
by Japanese multinationals abroad, find that industries with larger local sales are more 
likely to engage in overseas R&D. Cantwell and Piscitello’s (2005) regional analysis of 
inter-industry spillovers and diversification externalities in Europe finds a positive (but 
weak) impact of regional Gross Domestic Product (GDP) on the number of patents 
awarded to subsidiaries. To control for the influence of market size and purchasing 
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power, we use the Gross Domestic Product and the Gross Domestic Product per capita of 
host countries. 
 
S&T capabilities of host countries 
Several surveys show that scientific and technological capabilities of host countries are 
an important factor in explaining R&D activities of MNCs (see, for example, Florida 
1997; Edler et al. 2002; EIU 2004; and Thursby and Thursby 2007). Similar results are 
found in econometric studies. Kuemmerle (1999), for example, finds that world-wide 
pharmaceuticals and electronics MNCs with R&D facilities in foreign countries are more 
likely to develop sophisticated R&D when the host country has a relative advantage in 
terms of R&D intensity, scientific achievements and quality of human resources. Kumar 
(2001), based on data from US and Japanese affiliates, finds that national technological 
effort, measured by R&D over GNP, attracts a greater proportion of the R&D performed 
in affiliates. This pattern holds for both US and Japanese affiliates.  
Feinberg and Gupta (2004), using data for US-owned affiliates in R&D-intensive 
industries, find that the probability of conducting R&D in foreign locations is positively 
associated with the total R&D expenditure by other firms (including both US affiliates 
and non-US affiliates) from the same industry firms within the host country. Ito and 
Wakasugi (2007) find that Japanese affiliates are more likely to locate R&D labs in 
countries that have more researchers. Results are less clear in Almeida and Phene (2004). 
Using a sample of US multinational enterprises engaged in the semiconductor industry, 
they find that the technological strength of host countries has a significant and positive 
effect on patent counts when subsidiaries have previous experience in patenting. But the 
relationship does not hold when subsidiaries have one or fewer patents in the previous 
five years.  
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Todo and Miyamoto (2002), for the case of Indonesia find that knowledge 
diffusion from multinational enterprises requires foreign or domestic efforts in R&D and 
human resource development. Fernández-Ribas, Shapira and Youtie (2006) for Malaysia 
find that the average level of domestic R&D expenditures explain to a great extent the 
probability that a MNC engages in innovation activities in all the parts of the innovation 
value chain , including R&D, design and marketing activities, in the host country. 
Cantwell and Piscitello (2005) find evidence of the effects of regional intra- and inter-
industry spillovers on the probability that a US affiliate engages in R&D. To control for 
the influence of overall scientific strength of host countries, we propose to include a 
continuous variable on the number of scientific and technical publications (in all fields of 
science) originating in each host country.  
 
Firm-level control variables 
Firm’s experience in host countries 
Several contributions in the management literature pinpoint the role of subsidiary 
development in the expansion of innovation activities abroad (see for example, 
Birkinshaw et al. 1998; Subramaniam and Venkatraman 2001; Rugman and Verbeke 
2001; Furu 2001). These authors find that subsidiary-specific characteristics, such as size, 
age or managers’ leadership behavior, influence the type of innovation activities that 
affiliates perform. A subsidiary’s ability to overcome the “liability of foreignness” is 
another related topic mentioned in this regard (Zaheer and Mosakowski 1997; Sofka 
2006). MNCs with operations in foreign locations may encounter institutional and 
cultural barriers that increase costs and reduce profitability of R&D projects (Bakerma et 
al. 1996). Managers’ ability to overcome these barriers is a crucial point that may help to 
explain why some subsidiaries are doing more innovation than others. While we are not 
able to control for all these elements, we can test whether a firm’s experience in a host 
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country positively affects the number of subsequent patents developed in that country. To 
test this hypothesis we compute the number of nanotechnology patents invented in a host 
country during prior period. 
 
Incumbent advantages 
Our second firm-level control variable refers to firms’ incumbent role in nanotechnology. 
It is plausible to propose that prior experience in the formal process of patenting results in 
the development of tacit knowledge and capability in the field which, in turn, can be 
applied to subsequent research and innovation activities. As pointed out by Rothaermel 
and Thursby (2007), incumbent firms may have an initial competitive advantage due to 
their higher level of tacit knowledge in the field. We therefore include in our analysis a 
variable for the number of pre-sample nanotechnology patents assigned to a firm. 
 
Firm technological capabilities 
Finally, we control for the scale of a firm’s innovation capabilities by using total USPTO 
patents awarded to a sample firm in all technological fields. Although corporate R&D 
expenditures could be used, this raises some concerns. On the one hand, it is difficult to 
find an accurate measure of R&D investment that captures all research activities done by 
a major corporation and its often many affiliates. On the other, according to systemic and 
evolutionary models, R&D is just one input to the innovation process. Hence, instead of 




3. Data sources and data characteristics 
The model explained in previous section is estimated using a set of 25 US-based firms 
with the greatest number of nanotechnology-combined patents.7 This includes patents 
granted by the US Patent Office (USPTO) and by the European Patent Office (EPO), as 
well as patent applications filed under the Patent Cooperation Treaty (PCT) at the World 
Intellectual Property Organization (WIPO). By selecting patent data from more than one 
patent office we seek to have a more representative global picture of the inventive 
activities of US firms. In total, 3742 patents are assigned to these companies and their 
subsidiaries during 1997-2006.  
To obtain this data, we searched the global database of nanotechnology patents 
developed by the Program in Research and Innovation Systems Assessment (CNS-ASU 
Center for Nanotechnology in Society) at Georgia Tech. This database contains patent 
abstracts for the period 1990-2006 (mid-year) selected using the nanotechnology search 
term described in Porter et al. (2007). The dataset includes awarded patents from USPTO, 
EPO, JPO and German, UK, and French patent offices, patent application filings at 
WIPO, and patents from an INPADOC search of 72 issuing countries. In order to avoid 
duplicate patents for the same invention, this database generates one patent per patent 
family.8  
                                                 
7 These companies have 50 or more nanotechnology combined patents during the period under 
study. By industry category (using the Dow Jones Industry Classification Benchmark), the 
companies are: automobiles and parts: Ford Motor Company; chemicals: Dow Chemical 
Company, EI Du Pont de Nemours, Exxon Mobil Chemical, PPG Industries, Rohm & Haas; 
computer hardware: Hewlett-Packard, International Business Machines, Lucent Technologies, 
Seagate Technology; electronic office equipment: Xerox; general industrials: 3M, General 
Electric, Honeywell International; household goods: Procter & Gamble; leisure goods: Eastman 
Kodak; materials: Hyperion Catalysis*; personal goods: Kimberly-Clark; semiconductors: 
Advanced Micro Devices, Applied Materials, Intel, Micron Technology, Texas Instruments; 
telecommunications equipment: Corning Incorporated, Motorola. *Although not a large MNC, this 
is an internationally-active company in the top 25 of all US nanotechnology patenting companies. 
We have thus included it in the analysis. 
8 Initially we considered all patent offices included in the dataset. However, we found that, except 
for USPTO, EPO and WIPO, other patent offices did not have complete information on the 
location of inventor. As a result, we only used awarded patents by USPTO and EPO and granted 
WIPO PCTs. As we are not comparing patent activities of companies from different countries, the 
use of different patent offices is appropriate and desirable.  
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To develop an accurate picture of the invention activities carried out abroad by 
private corporations, our analysis is based on consolidated group companies of the 
ultimate parent company. Companies are assigned to the location of the corporation’s 
registered office. Consolidated majority-owned subsidiaries are obtained from several 
corporate directories, including Dun and Bradstreet, Who Owns Whom, Mergent, and 10-
K reports submitted to the US Securities and Exchange Commission (SEC). Mergers and 
Acquisitions (M&A) after 2005 and joint-ventures by corporate firms are not considered. 
Individual patents were then unified into corporate families.9 Information on the location 
of the inventor was then extracted from the patent records assigned to corporate groups. 
Finally, inventor cities were assigned to countries and host countries selected as having at 
least one patent (totally or partially) assigned.10 11 
We complement this data with information extracted from four other different 
sources. The nanotechnology publications used to compute the citation index come from 
the Georgia Tech nanotechnology publications database. This database was constructed 
using the methods described in Porter et al. (2007). It contains nanotechnology 
publication records for the period 1990-2006 (mid-year). Scientific and technical 
publications (in all fields) to measure host country overall scientific strength were 
obtained from the Thomson ISI (Web of Science) Science Citation Index. Market-size 
variables were extracted through the World Bank macroeconomic database. To obtain 
firm’s level of overall technology strength we did a search at USPTO of consolidated 
names of companies.  
                                                 
9 An extensive manual checking was undertaken to unify name variance of assignee firms and 
their subsidiaries. As noted by Griliches (1990), patent offices do not employ consistent company 
codes for each corporation.  
10 The geographic address of the inventor is a more desirable indicator of the site of the inventive 
process than the location of the assignee, because the assignee location may be biased towards 
head-office administrative locations (Jaffe, Trajtenberg and Henderson 2002). 
11 The main difficulty with the inventor location is that regional codes may correspond to country 
codes. For example, country/state code “CA” sometimes refers to Canada and other times to 
California, “IL” to Israel or Illinois, “IN” to India or Indiana, and “ID” to Indonesia or Idaho. To 
avoid misleading results regarding inventor cities and countries, inventor cities were assigned 
manually to correct countries/states. 
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Table 1 provides a detailed description of variables employed in our analysis. 
The dependent variable of the model refers to the number of patents invented (totally or 
partially) in a host country during 2002 and 2006 assigned to a sample firm. The 
technology diversity index is based on three-digit level IPC classes for 1997-2001. The 
citation index is measured using nanotechnology publications originating in a host 
country during 1997-2001, and times cited by 2006. Gross Domestic Product and Gross 
Domestic Product per capita are averaged for 1997-2001. These figures are expressed in 
logs of US dollars converted at purchasing power parity (PPP) exchange rates (current 
international dollars). S&T publications originating in each host country are also 
averaged for 1997-01 and expressed in logs. Firms’ incumbent role in the field of 
nanotechnology is computed as the number of nanotechnology patents assigned to a 
sample firm during 1992-1996. Firms’ experience in developing invention in a host 
country is measured as the total number of patents invented in a host country by a firm 
during the period 1997-2001. Firm size is proxied by the average number of USPTO 
patents assigned to a firm during 1997-2001. 
 
3.1 Data characteristics 
Our dataset represents about 13% of the total number of nanotechnology patents 
contained in the USPTO, EPO and WIPO dataset. As can be seen in Figure 1, the gap 
between sample firms and patents assigned to other organizations increases over our 
study period. This observation corroborates that large incumbent firms played a critical 
role in the early development of nanotechnology, taking associated risks and investing 
resources, and as a result lead early patenting in the field. However, as the field 
developed, incumbent firms tended to lose the temporary monopoly that they have had in 
initial stages of nanotechnology.  
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Overall, we observe that the total number of patents co-invented abroad by these 
companies more than double during 1997-2001 and 2002-2006. However, when 
compared to the total number of patents invented at home, we observe that the percentage 
of patents co-invented abroad (totally or partially) drops from 17% in 1997-01 to 13% in 
2002-2006 (table 2). These results are in line with Patel and Pavitt’s (1991) predictions 
about the small proportion of R&D activities performed abroad by US large firms. They 
also corroborate the idea posed by Cantwell (1995) that US firms tend to internationalize 
a small proportion of their R&D activities, particularly for those technologies which have 
a high strategic importance and are multidisciplinary by nature. The superiority of US 
firms and universities in nanotechnology may be suggesting that MNCs are indeed 
globalizing part or their R&D process, but the growth of the number of patents invented 
at home is more important.  
Invention takes place primarily in highly industrialized countries such as Canada, 
Germany, France, UK, Belgium or Japan (see Figure 2). These countries attract more 
than two-thirds of the invention activities developed abroad by US companies. When 
comparing dynamics for five year periods 1997-2001 and 2002-2006, several interesting 
facts emerge. First, we observe the inclusion of new host countries, such as India, South 
Korea, Malaysia, Singapore, Norway, Portugal and Turkey in the most recent period. 
Although these new places do not have large numbers of patent counts, this development 
is indicating a dispersion trend. Second, the proportion of invention activities developed 
by US companies in Canada, Germany, UK, France, Belgium and Italy decreases, while 
invention taking place in other developed economies, such as Japan, the Netherlands and 
Switzerland, grows.  
Table 3 reports descriptive statistics for sample firms. Geographic dispersion of 
the inventive process varies across companies. For the majority of companies, inventions 
developed abroad are invented in four or five different countries. However, there are 
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some exceptions. General Electric (GE) for example is the most widely dispersed 
company with patents co-invented in 13 different countries, International Business 
Machines (IBM) and Procter and Gamble (PG) are also among quite geographically 
dispersed companies. Xerox has the largest number of patents developed abroad during 
1997-2001 and 2002-2006 (51 and 78, respectively). A majority of these patents are co-
invented in Canada. This is not very surprising, given the fact that Xerox has an R&D 
facility “Xerox Research Center Canada” since 1974, which has over 1000 patents (10% 
in nanotechnology). Heterogeneity across countries is also present in terms of 
technological diversity and patent quality (see Figures 3 and 4).  
Larger host countries such as Germany, France and Great Britain are the most 
diversified in terms of different nanotechnology patent classes, while developing 
countries are the least diversified. The reciprocal of the Gini coefficient takes values 
larger than 0.5 for the first group of countries, and less than 0.02 for the second group. 
Publication quality is lead by the Netherlands Israel, Canada, Ireland, Germany, Great 
Britain, Belgium, and Sweden, which have on average more than 15 publication citations 
in nanotechnology per year, while countries such as, Russia and Thailand have less than 7 
citations per year. 
 
4. Estimation method and econometric results 
Empirical models with non-negative count dependent variables are commonly estimated 
using the Poisson distribution (Wooldridge 2002). However, our response variable 
exhibits a series of features that may restrain the use of the Poisson model. First, our 
dependent variable is skewed-distributed. Some firms have a dispersed location pattern 
while others just invent in one or two host countries. As a result, there are some host 
countries with a high number of patents invented totally or partially by US companies, 
while other host countries have few of these inventions. The Poisson model is less 
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adequate in such cases, because it assumes equi-disperison between the conditional 
variance of the count variable and its conditional mean. In this case, it is more efficient to 
use negative binomial models, which allow for overdispersion by including a parameter 
alpha into the Poisson distribution.  
 Second, as our dependent variable is set to have all possible firm-country 
combinations, it contains a large number of zeros. To deal with this issue, we consider 
models which differ from the standard negative binomial by considering different 
distributions for the zero and non-zero counts. Lambert (1992) and Greene (1994) 
provide an extensive overview of the characteristics of these models. Basically, these 
models estimate the zero count regime using the cumulative logistic distribution (logit 
model) or the cumulative normal probability (probit model), and the non-zero counts 
using a maximum likelihood negative binomial model. 
 
4.1 Econometric results 
Tables 4 and 5 show econometric results, using five different right-hand specifications. 
The first model includes host country control variables as well as the firm’s experience in 
the nanotechnology field and in patentable R&D. We then estimate three specifications: 
one including our measure of technological diversity, a second with the publication 
quality measure, and a third including both measures. Finally, we incorporate a variable 
for a firm’s experience in developing inventions in host countries. These specifications 
are initially estimated using a negative binomial maximum-likelihood model. As can be 
seen in table 6, a likelihood ratio test of presence of overdispersion in our dependent 
variable confirms that alpha (the overdispersion parameter) is significantly different from 
zero, suggesting that the negative binomial is preferred to the Poison regression. The 
Vuong test suggests that we can not reject the null hypothesis that the zero inflated 
binomial model is a better choice than the negative binomial model. The value of the 
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Vuong test also indicates that the zero-inflated negative binomial is favored against a 
zero-inflated Poisson model in the fifth specification.  
Our estimations confirm previous evidence on the positive impact of overall 
scientific strength of host countries. All of our five specifications confirm that countries 
with more S&T capabilities attract more inventive activities by US MNCs. Market size, 
measured by the lagged value of GDP and GDP per capita, has a more erratic pattern. Not 
surprisingly, larger firms, with more patentable R&D activities, tend to do more 
innovative activities abroad. Firm’s previous experience in nanotechnology also increases 
the expected number of patents developed in foreign countries. Experience in a host 
country is also positively related with the expected number of patents developed in a host 
country.  
More interestingly, our measure of technological diversity turns to be quite 
important in explaining the inventive process of US MNCs in foreign locations. We find 
that countries which have patent activities in broader patent classes are attracting more 
R&D from US companies. This result seems to corroborate the importance of scope 
economies in the production of knowledge and the importance of diversity externalities in 
the globalization of R&D. It may be indicating that interdisciplinarity in a new field 
stimulates productivity. On the other hand, publication quality also induces a positive 
change in the probability of inventing in foreign locations, but it is not always significant.  
Overall, our estimated models suggests that host countries with more scientific 
resources and more technological diversity in the field of nanotechnology are more likely 
to attract invention activities by US firms. These are primarily advanced developed 
economies: at least in the case of MNC patentable nanotechnology R&D, there is not a 
wholesale shift to emerging developing countries. Regarding the characterization of 
firms, estimations suggest that firms with more patentable R&D and more experienced in 
the field of nanotechnology and in developing nanotechnology activities in host countries 
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are also more likely to do invention in host countries.  We interpret these results as 
suggesting that host country nanotechnology capabilities are important to attract 
innovative activities of US MNCs, but as the interdisciplinary and convergent nature of 
nanotechnology evolves, access to a broadly diversified knowledge base becomes 
important, which increases the relative attractiveness of home locations.  
 
5. Conclusions 
This study investigates how technological complexity and the convergent character of an 
emerging technology influences innovation location decisions by US MNCs. We suggest 
that as fields evolve and S&T capabilities spread over a larger number of countries, new 
explanatory factors should be explored in order to understand firms’ complex choices 
about where to locate invention activities. In particular, we anticipate that a host 
country’s technological diversity and its scientific excellence in the field may be two 
important factors that explain inward research activities from foreign companies.  
To investigate these hypotheses we selected the most technologically active US-
owned firms in the field of nanotechnology during the ten year period, 1997-2006, and 
studied how foreign country diverse technological capabilities and scientific performance 
affect the probability of attracting invention activities by these leading US 
nanotechnology R&D companies. In order to deal with potential time issues, we set up an 
appropriate lagged econometric model on the number of patents invented in different host 
countries. Our model also controls for other country-level characteristics, such as market 
size and overall scientific strength. From the firm side, we control for previous 
experience in developing innovation activities abroad, the ability to commercialize R&D, 
and experience in the development of nanotechnology activities. 
Our results point to the relative importance of having a diversified technological 
base. We find that technological breadth, measured by the reciprocal of the Gini 
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coefficient, is a strong predictor of the number of patents co-invented abroad by US-
companies. Our measure of scientific excellence is positively correlated with US firm’s 
patenting activities, but is not significant in all specifications. The positive impact of host 
country overall scientific strength is confirmed. These results seem to be consistent with 
the idea that R&D location decisions are driven by firms’ desire to access 
multidisciplinary knowledge bases and globally competitive S&T. Our findings regarding 
the ambiguous role of market size are consistent with recent studies on patenting 
(Belderbos 2006; Almeida and Phene 2004). At the firm level, we find that previous 
experience in host countries, technological strength in the field and overall strength of 
patentable R&D positively impact a firm’s capacity to develop foreign R&D activities. 
These results may suggest that inventing abroad is a path dependent learning process, and 
that tacit knowledge in the field is important.  
These results have several implications for both governments and firms. We find 
that the attraction of foreign R&D in the field of nanotechnology is driven by a 
combination of factors.  Particularly important is the ability of local innovation systems 
to adapt to the increasing interdisciplinarity nature of the field. Having S&T capabilities 
also helps to attract foreign R&D, but as scientific and technological competencies spread 
globally, the quality of science may be another distinguishing factor that attracts foreign 
investment in R&D as well. This emphasizes the importance of having flexible horizontal 
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Number of patents invented abroad (totally or partially) assigned to a 
sample firm during 2002-2006. Dependent variable of the model. 
Technological diversity in 
nanotechnology 
Reciprocal of the Gini index. Based on three-digit IPC patent classes 
during 1997-2001. Attracts complex multidisciplinary inventive 
activities in nanotechnology. 
Scientific quality in 
nanotechnology 
Weighed number of citations received by 2006 of nanotechnology 
publications originating in a host county during 1997-2001. Attracts 
inventive activities in nanotechnology which have a high science 
based component. 
Market size Average GDP 1997-2001 (in logs) and average GDP per capita 1997-
01 (in logs). Attracts inventing activities in nanotechnology because 
of high demand for applications and products. 
Overall scientific strength Average number of S&T publications originating in a host country 
during 1997-2001 (in logs). Attracts complex multidisciplinary 
inventive activities in nanotechnology. 
Previous nanotechnology 
patents invented abroad 
Number of nanotechnology patents invented abroad (totally or 
partially) assigned to a sample firm in 1997-2001. Firm’s previous 




Number of nanotechnology patents assigned to a sample firm during 
1992-1996. Previous experience in nanotechnology positively affects 
the capacity to develop nanotechnology abroad. 
Overall firm technological 
strength  
Average number of USPTO patents assigned to a sample firm during 
1997-2001. Strength of patentable R&D (proxy for R&D 
expenditures) positively affects the capacity to develop technology 
abroad (including nanotechnology). 
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Table 2. USPTO/EPO/WIPO nano patents awarded to top US firms, 
developed at home and abroad.  
 
Variable 1997-2001 2002-2006 
Total number of patents 1187 2555 
Patents co-invented abroad  182 (17%) 335 (13%) 
Patents totally invented abroad 117 (10%) 206(8%) 
 
Note: Percentages are relative to total number of patents with complete information about 
inventor locations. We did an extensive analysis of the distribution of missing cases, and 
arrived to the conclusion there were no systematic differences across patent offices. 
Only1%-2% of patents have missing information on inventor city.  
 
 
Table 3. Descriptive Statistics 
 
 
    Note: Observations = 625 
 
 
Variable Mean Std. Dev. Min Max 
Patents invented abroad t 0.59 3.56 0 78 
Patents invented abroad t-1 0.33 2.32 0 51 
Technological diversity t-1 0.25 0.19 0 0.73 
Scientific excellence t-1 13.27 4.24 7.70 23.04 
Log GDP t-1 13.10 1.25 10.29 15.34 
Log GDP per capita t-1 9.63 0.72 7.74 10.41 
Log S&T publications t-1 9.51 1.17 6.76 11.27 
Pre-sample patents t-2 19.20 18.13 0 68 
Firm’s technological strength t-1 5.57 1.85 0 7.91 
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Table 4. Results Poisson and negative binomial (nb) specification predicting number of patents invented in a host country by US 
MNCs 
 
 Poisson nb Poisson nb Poisson nb Poisson nb Poisson nb 




































































































Technological diversity t-1   1.31 (0.40) 
2.52** 















































LR chi2 528.27*** 85.31*** 538.77*** 89.04*** 592.02*** 87.93*** 594.93*** 90.51*** -569.78*** 127.33***
Log likelihood -857.85 -413.72 -852.60 -411.85 -825.97 -412.40 -824.52 -411.12 1104.4 -392.71 
 Pseudo R2 0.2354 0.0935 0.2401 0.0976 0.2638 0.0963 0.2651 0.0992 0.49 0.1395 
 





Table 5. Results negative binomial (nb) and zero-inflated negative binomial (zinb) predicting number of patents invented in a host 


























Note: Standard deviation in parenthesis. * p<0.10; **p<0.05; ***p<0.01. Marginal effects reported 
 
 (1) (2) (3) (4) (5) 
 nb zinb nb zinb nb zinb nb zinb nb zinb 































































































Technological diversity t-1    0.57* (0.31) 
0.91** 

























Log Likelihood -413.72 -409.62 -411.85 -406.60 -412.41 -409.61 -411.12 -404.22 -392.71 -368.52 
Chi-Square test 85.31*** 32.40*** 89.04*** 31.91*** 87.93*** 32.40*** 90.51*** 35.98*** 127.3*** 64.98*** 
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Note: a The hypothesis being tested is that the overdispersion parameter (alpha) is zero. A 
likelihood ratio test indicates that we can not accept the null hypothesis that the negative 
binomial distribution is equivalent to the Poisson distribution. bThe null hypothesis is that 
a zero-inflated negative binomial fits better the data than an ordinary negative binomial. 
The test indicates that we can accept this hypothesis. 
Specification (1) (2) (3) (4) (5) 
Overdispersion testa 888.3*** 881.5*** 827.1*** 826.8*** 354.1*** 
Vuong Testb 1.55*  1.59*  1.87**  1.94** 3.19 ***  
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Figure 1. Annual number of USPTO/EPO/WIPO nano patents granted to all 
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Figure 2. Location patterns of inventive activity in nano by top U.S. 











































Figure 3. Technological Diversity Index 1997-2001 
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